G. Sitta Sittampalam

Dr. Sittampalam has over 23 years of experience in drug discovery and development in the pharmaceutical industry (Eli Lilly & Co, Indianapolis, IN). He served four years in academic drug discovery and high-throughput screening as the Deputy Director of the Institute of Advancing Medical Innovations and was a professor of Pharmacology, Toxicology, & Therapeutics at the University of Kansas Cancer Center (2007-11).

His current interests include developing physiologically-relevant 3D cellular models for drug discovery, circulating tumor cells, and cancer stem cells as biomarkers. He was a member of NIH RoadMap MLPCN Grants Review Panels (2005-2009) and has served on stem cell research grant review panels in Maryland (MSCRF) and California (CIRM). He is currently the Editor-in-Chief of the Assay Guidance Manual, sponsored by NCATS and NIMH. Dr. Sittampalam served on the editorial board of the Journal of Biomolecular Sciences (2007-present) and the scientific advisory boards of Science Translational Medicine, and Science Exchange Inc.